Supported by the robust PEA economics (refer to Fortuna news release dated October 15, 2025 ), the Company is advancing a feasibility study targeted for the second quarter of 2026 and is progressing ...
Myriad Uranium Corp. (CSE: M) (OTCQB: MYRUF) (FSE: C3Q) (“Myriad” or the “Company”) is pleased to announce that it has entered into ...
Five new Lower Merion commissioners were sworn in Monday evening: Michael Daly, Charles Gregory, Christine McGuire, Craig ...
A research team presents an overview of recent advances in the microbial biosynthesis of L-tryptophan (L-Trp) and its ...
VANCOUVER, BC / ACCESS Newswire / January 8, 2026 / Banyan Gold Corp. (the "Company" or "Banyan") (TSXV:BYN)(OTCQB:BYAGF) is ...
You may unsubscribe at any time. By signing up, you agree to our terms of use and privacy policy. This site is protected by reCAPTCHA and the Google privacy policy and terms of service apply.
Multiple milestones anticipated from late-stage portfolio including topline results from DIAMOND Phase 3 trials with OCS-01 eye drops in diabetic macular edema (DME) expected in Q2 2026 Riad Sherif, M ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results